http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1936064-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93b626f3d2827c6e57a197da4642fada
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6949
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C203-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C203-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
filingDate 1969-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dffc4e4816b645f9668604b3e9d04e2
publicationDate 1971-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-1936064-A1
titleOfInvention Inclusion compounds made from pharmaceutically active organic nitrates and bile acids
abstract Inclusion compounds of bile acids and organic nitrates selected from glyceryl trinitrate, penta-erythritol tetranitrate, mannitol hexanitrate, erythritol tetranitrate and isosorbide dinitrate. Complexes are readily absorbed from the gastro-intestinal tract. The organic nitrates above are mainly used in treatment of angina pectoris. Solution of bile acid and organic nitrate in inert solvent which dissolves both. Product crystallises. Preferred molar ratio of nitrate:bile acid is 1:2. Desoxycholic acid (2.35 g.) and PETN (316 mg) were dissolved in 20 ml. of a 1:1 mixture of methanol and benzene with warming. The soln. was cooled to 0 deg.C and the crystals which separated were collected to give a PETN/desoxycholic acid complex with a ratio of 1:2. The mother liquors gave a mixture of inclusion compounds having a PETN/bile acid ratio of from 3:1 to 6:1.
priorityDate 1969-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415807171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510

Total number of triples: 36.